Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group. 1996

D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
Izaak Walton Killam Children's Hospital, Halifax.

The purposes of this report are to reaffirm concordance difficulties with the acute myeloid leukemia (AML) French-American-British (FAB) classification, to present the frequency of previously delineated AML syndromes in pediatric patients and to describe additional characteristic AML profiles utilizing composite morphologic, cytogenetic and immunophenotypic data. Profiles of 124 children with acute myeloid leukemia (AML) and 13 children with myelodysplastic syndrome entered on the Childrens Cancer Group (CCG) pilot study CCG-2861 were examined. Concordance between institutions and reviewers for FAB designation was 65%. Discordance was found principally between M1 and M2, M2 and M4, and M4 and M5. In 49% of marrow specimens, leukemic blasts expressed at least one T lineage-related antigen; 24% expressed the B lineage-related antigen CD19. CDw14 correlated with FAB M4 or M5 morphology and was the only surface antigen associated with a specific FAB subtype. Normal karyotypes were found for 15% of the 75 children with satisfactory karyotype preparations. Recurring aberrations, found in 76% of children, included t(15;17)(q22;q11), t(8;21)(q22;q22), inv(16)(p13q22), rearrangements of band 11q23, t(6;9) (p23;q34), trisomy 8 and monosomy 7. Results from this pilot study and from the current CCG randomized trial correlating morphology, immunophenotyping and cytogenetics, will help to classify AML into unique subgroups with differing clinical consequences or therapy requirements.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
September 1981, Blood,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
March 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
April 1988, British journal of haematology,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
January 1983, Medical and pediatric oncology,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
February 1994, Cancer genetics and cytogenetics,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
January 1991, Leukemia & lymphoma,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
January 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
October 1985, Cancer treatment reports,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
March 1983, Cancer,
D R Barnard, and D K Kalousek, and S R Wiersma, and B J Lange, and D R Benjamin, and D C Arthur, and J D Buckley, and N Kobrinsky, and S Neudorf, and J Sanders, and L P Miller, and D C Shina, and G D Hammond, and W G Woods
April 2000, Leukemia,
Copied contents to your clipboard!